Rossari Biotech receives three times the demand of shares on offer in IPO
On Tuesday, the IPO garnered bids for 24.3 million shares as against 8.17 million available
)
premium
Axis Capital and ICICI Securities are the investment banks handling the issue. Illustration: Ajay Mohanty
Rossari Biotech has received three times the demand of shares on offer in its initial public offering (IPO), which closes on Wednesday.